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treated with the high-affinity tissue angio-
tensin-converting enzyme (ACE) inhibitor
quinaprilat had significantly better recov-
ery of regional wall motion, a lower inci-
dence of ventricular arrhythmias, and a
smaller infarct size than controls. When the
low-affinity tissue ACE inhibitor enalapri-
lat was administered, the decrease in infarct
size was less (24% enalaprilat vs 14%
quinaprilat; P  .0001). The beneficial ef-
fects of quinaprilat’s action could be ex-
plained by its superior preservation of en-
dothelial function, since quinaprilat-treated
hearts had significantly greater coronary
arterial relaxation in response to bradykinin
(66% quinaprilat vs 32% enalaprilat; P 
.0001). When the bradykinin antagonist
HOE140 was added to the quinaprilat-
treated hearts, the protective effect on en-
dothelial function was abolished and these
hearts had a significant increase in infarct
size (48% quinaprilat  HOE vs 14%
quinaprilat; P  .0001).
I agree that ACE inhibitors enhance
myocardial protection during cardioplegic
arrest. However, ACE inhibitors are not all
equally protective. ACE inhibitors with
high tissue ACE inhibition such as
quinaprilat result in better preservation of
endothelial function, which decreases isch-
emic necrosis. This improvement in endo-
thelial function appears to be bradykinin-
mediated. I concur with Korn and
coworkers that high-affinity tissue ACE in-
hibitors may play an important role in en-
hancing cardioplegic protection during cor-
onary revascularization.2,3
Harold L. Lazar, MD
Professor of Cardiothoracic Surgery
Boston Medical Center
Cardiothoracic Surgery
Boston, MA 02118
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Tracheal replacement
To the Editor:
It is encouraging that efforts continue to
produce a “tissue-engineered trachea.”1
since this is about the only technique of the
many attempts at tracheal replacement by a
variety of approaches over more than 50
years that seems to offer any real promise.2
I question, however, whether the experi-
ments reported succeeded in forming “the
structural component of a functional tra-
cheal replacement.”
Although visually resembling a trachea,
the construction described failed to func-
tion (in sheep) over 5 and 7 days in 2
animals (with resultant malacia) or longer
than 2 days in 4 animals (with stenosis).
The authors’ findings suggest that inflam-
matory response might be responsible for
degeneration of the graft. Cell density and
hydroxyproline content support this hy-
pothesis. Conversion toward scar probably
had begun, even with survival of some
cartilage. The authors also allude to future
advisability of assuring blood supply,
which may indeed be a critical factor in this
early deterioration of the implant. One of
the keys to failure, even of autotrans-
planted free tracheal segments of any sig-
nificant length, has been failure of blood
supply, despite muscular or omental
pedicles. Very short tracheal grafts, of
course, are of no potential clinical use.
A subject that is deferred by the authors
to later experimentation, perhaps with en-
gineered epithelium, is the lack of epithe-
lial coverage in these experiments. In time
this would lead to graft obstruction by cic-
atrization. Epithelium in general has failed
to recolonize any extended length of tra-
cheal replacement by ingrowth from the
normal tracheal ends alone.
I shall look forward with interest to
future reports by this and other groups us-
ing tissue engineering in an effort to meet
the challenge of fashioning a usable tra-
cheal prosthesis for the rare occasion when
it is indeed needed.
Hermes C. Grillo, MD
Division of Thoracic Surgery
Massachusetts General Hospital
32 Fruit St
Boston, MA 02114
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Cardiac herniation after
intrapericardial pneumonectomy
To the Editor:
The brief communication by Baisi and as-
sociates1 reporting a case of cardiac herni-
ation after intrapericardial pneumonectomy
is almost identical with a case report in
another journal.2 Both reports fail to men-
tion that chest tubes were deployed after
the pneumonectomy. (They can clearly be
seen in their respective illustrations.)
The previous case2,3 instigated a spir-
ited correspondence4,5 centering on the
role, if any, of chest tubes after pneumo-
nectomy and their relation to cardiac her-
niation. The current case also fails to men-
tion a chest tube in the left posterior
thoracic gutter clearly seen on the com-
puted tomographic scan (see Figure 1). No
mention is made of its presence or mode of
use. Rather the authors emphasize (without
justification or substantiation in my mind)
that the induction chemotherapy was to
blame. Actually the initial closure of the
postpneumonectomy pericardial defect
failed because the sutures, placed under
tension, cut through—a mechanical prob-
lem, not a neoplastic or chemotherapeutic
problem.
The empty postpneumonectomy space
is not to be equated with that containing
variable amounts of lung tissue, which re-
quire chest tubes attached to suction. Using
such continued suction in a postpneumo-
nectomy space even for a short period of
time is to court disaster produced by exces-
sive mediastinal shift and, in some cases,
cardiac herniation. Despite the opinion of
Walker4 of the hazards of chest tubes after
pneumonectomy, Cooley5 expressed it well
when he said that he routinely used tubes
after pneumonectomy but that “when not in
use the tube should be clamped.” [italics
mine.]
Paul A. Kirschner, MD, FACS
Department of Cardiothoracic Surgery
Box 1028
Mount Sinai Medical Center
1 Gustave L. Levy Place
New York, NY 10029
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Reply to the Editor:
Kirschner’s comment focuses on two
points: the use of a chest tube after pneu-
monectomy and the similarity of our case
to one recently reported in another journal.1
Regarding the use of a chest tube after
pneumonectomy, it is worthwhile to repeat
the commentaries of Nazari and Cooley
cited in Kischner’s letter.2,3 It is a personal
choice of the surgeon, and no evidence
exists supporting one option or the other.
However, we would like to remind Kis-
chner that after pneumonectomy, the chest
tube is not attached to continued suction
and does not “court disaster produced by
excessive mediastinal shift,” as he says, but
is connected to an appropriately balanced
pneumonectomy drain set.4 This is com-
pletely different from the one-way valve
used after partial lung tissue resection. It is
designed to achieve both positive and neg-
ative pressure control avoiding any abnor-
mal mediastinal shift.
We reply to the second point of Kis-
chner’s comment stressing the role played
by induction chemotherapy in our case, as
emphasized both in the title and in the
discussion of our article. In the past 5 years
we performed 208 pneumonectomies, 47
with intrapericardial vessel ligation. The
pericardial defect was closed directly by
stitches in 35 cases and by a pericardial
patch in 12 cases in which the defect was
too large and a direct suture would have
been under tension. The reported case of
cardiac herniation was the first in our ex-
perience. We are sure that the closure we
performed in the first operation was not
under any abnormal tension, that the peri-
cardium was fibrotic because of the previ-
ous chemotherapy, and that this played a
major role in its disruption.
The message we would like to give is
not that cardiac herniation may happen af-
ter intrapericardial pneumonectomy—this
is widely known—but that it is more likely
if the patient has undergone previous in-
duction chemotherapy. In these cases, the
use of pericardium to close small defects
can also be recommended.
Alessandro Baisi, MD
Ugo Cioffi, MD
Luigi Santambrogio, MD
University of Milan
Department of Surgery Ospedale
Maggiore Policlinico IRCCS
Milan, Italy
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Intussusception and spontaneous
amputation of the esophagus
To the Editor:
I read with interest the case of a patient
with acute leukemia and segmental esoph-
ageal necrosis reported by Salo and asso-
ciates.1 The authors imply that intussuscep-
tion led to ischemia, and circumferential
full-thickness loss of the esophagus was
repaired “without interruption.” Both as-
sumptions may be challenged. The patient
had no risk factor for gastroesophageal
intussusception,2 in which stomach is the
intussusceptum, not esophagus, and perfo-
ration, rather than necrosis, a reported com-
plication. Fungal infection of the esopha-
gus in leukemia, however, is known to
result in full-thickness necrosis and esoph-
ageal expulsion.3 Their final comment re-
lating to Aspergillus infection of the esoph-
ageal wall points to the likely cause of
necrosis.
A complete loss of all esophageal lay-
ers, no matter how short, is expected to
result in cicatricial stricture that may have
been delayed in this case by cytotoxic ther-
apy. Indeed, dysphagia later developed, ne-
cessitating further intervention. The medi-
astinal soft tissues may resemble the
esophageal lumen so that perforation is not
obvious. However, bare of epithelium and
exposed to esophageal contents, the medi-
astinum provides an entry to systemic in-
fection, particularly in an immunosup-
pressed state. Esophageal resection with
immediate or delayed reconstruction
should be considered even in this patient
population to prevent mediastinitis and re-
store swallowing.
Henning A. Gaissert, MD
Massachusetts General Hospital
Boston, MA 02114
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Reply to the Editor
We thank Gaissert for his very valuable
comments.
Spontaneous amputation of the esopha-
gus is a serious and rare event, and its exact
pathophysiology is not well understood.
There were several reasons that led us to
believe that intussusception, followed by
ishemic necrosis, may be an etiologic fac-
tor. Our patient had a hiatal hernia, as pre-
viously stated. Hiatal hernia is a widely
known risk factor for intussusception, as
well as dysphagia, a condition that devel-
oped after severe vomiting.1 On careful
inspection of Figure 1, one can see that the
inner circular muscle layer of the esopha-
gus is located superficially as a result of
intussusception.
Abildgaard and associates2 have de-
scribed total expulsion of the distal esoph-
agus in a severely immunocompromised
patient with Candida esophagitis. Multi-
factorial pathogenesis, including intussus-
ception, is presumable inasmuch as their
patient had also had regurgitation, vomit-
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